By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Candida albicans skin test antigen (monograph) > Candida Albicans Extract Dosage
Drugs
https://themeditary.com/dosage-information/candida-albicans-extract-dosage-11681.html

Candida Albicans Extract Dosage

Drug Detail:Candida albicans skin test antigen (monograph) (Introduction)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Diagnostic

0.1 mL intradermally

Comments:

  • Do not use to diagnose or treat Type I allergy to Candida Albicans.
  • The time required for induration response varies; the reaction usually begins within 24 hours and peaks between 24 and 48 hours.
  • Read the skin test at 48 hours by visual inspection and palpitation of the induration.
  • A positive reaction consists of an induration 5 mm or larger.

Use(s): Skin test antigen to assess cellular hypersensitivity to Candida Albicans

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

US BOXED WARNING(S):

  • This drug is intended for use by physicians experienced in the intradermal administration of a skin test antigen.
  • The expected response to this drug is a local area of inflammation at the skin test site.
  • The size of reaction depends on the sensitivity of the person receiving the test, but is usually dime to quarter size, with the maximum size reached between 24 to 48 hours.
  • Larger accelerated reactions can occur which may require treatment with local cold compresses and anti-inflammatory medication.
  • Systemic reaction can occur with skin test antigens; in certain individuals these reactions may be life-threatening or fatal.
  • Observe patients for at least 20 minutes following administration of the skin test.
  • Emergency measures, as well as trained personnel, should be available immediately in the event of a life-threatening reaction.
  • Never give this drug intravenously.

Serious adverse reactions should be reported to the manufacturer at (855) 855-1212 or the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Never give this drug intravenously; take care not to inject into a blood vessel.
  • This drug is intended for use by physicians experienced in the intradermal administration of a skin test antigen.
  • Inject intradermally on the volar surface of the forearm or the outer aspect of the upper arm.
  • Inject the antigen intradermally as superficially as possible, causing a distinct, sharply defined bleb at the skin test site.
  • Subcutaneous injection may lead to an unreliable reaction.
  • Use new syringes and needles for each patient; dispose of needles properly.

Storage requirements:
  • Refrigerate; do not freeze.

Monitoring:
  • Observe patients for at least 20 minutes following administration of the skin test.
  • Emergency measures, as well as trained personnel, should be available immediately in the event of a life-threatening reaction.

Patient advice:
  • Local reactions include redness, swelling, pruritus, excoriation, and discoloration of the skin; these usually subside hours or days after administering the test; skin discoloration lasts several weeks in some patients.
  • The antigen reaction may progress to vesiculation, necrosis, or ulceration.
  • There is a remote possibility of having a Type I anaphylactic reaction that may be life threatening.
  • Report any serious adverse reactions to your healthcare provider.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by